Extracorporeal Membrane Oxygenation Machine Market Report

Market Insights

"The global extracorporeal membrane oxygenation machine market size was estimated at USD 283.07 million in 2022 and is likely to grow at a CAGR of 5.60% during 2023-2028 to reach USD 393.64 million in 2028."

Wish to get a Free Sample? Register Here.

Extracorporeal membrane oxygenation (ECMO), referred to as extracorporeal life support (ECLS), is an extracorporeal method of offering prolonged cardiac & respiratory support to people whose heart and lungs are unable to offer a sufficient amount of gas exchange or perfusion to sustain life. The technique for ECMO is mainly derived from cardiopulmonary bypass that offers shorter-term support with arrested native circulation.

Market Dynamics

Market Drivers

The market is driven by a host of factors, some of which are noted below:

• Growing incidences of respiratory & cardiovascular disorders worldwide.
• ECMO is primarily used for both newborns & children and adults, suffering from cardiac or respiratory failure due to trauma, congenital disabilities, or severe infections.
• Moreover, expanding aging population, which is highly susceptible to chronic medical ailments.

Covid-19 Impact

The COVID-19 pandemic has moderately affected the extracorporeal membrane oxygenation machine industry. ECMO devices are widely used in the treatment of serious COVID-19 patients. Although, other applications of these devices, including heart procedures, witnessed a sharp decline in 2020.

Segment Analysis

Product Trends

"The oxygenators segment accounted for the largest market share."

The market has been classified into pumps, oxygenators, controllers, cannulas, and accessories. The oxygenators segment accounted for the largest market share of more than 30% in 2022 & is expected to maintain its dominance during the forecast period. Oxygenators exhibit acute exchange rates for different systems. The exchange rate of oxygenators is majorly due to pump head thrombosis, mechanical failure, and acute oxygenator thrombosis, thus bolstering market growth.

Application Trends

"The respiratory segment accounted for the largest market share."

The market has been classified into respiratory, cardiac, & ECPR. The respiratory segment accounted for a market share of more than 45% in 2022 & is expected to remain the largest market for ECMO during the forecast period. The rising prevalence of respiratory illnesses, as well as increased knowledge of ECMO techniques, are important market drivers. According to ELSO figures, nearly 2,600 patients in the United States with respiratory diseases received ECMO therapy in 2015. Due to the increasing incidence of cardiac surgery and increased knowledge regarding ECMO machines in cardiac surgery, the cardiac surgery sector accounted for a significant market share in 2022.

Regional Insights

"North America accounted for the largest market share."

North America accounted for the highest share of more than 35% in 2022 and is expected to grow at a robust CAGR during the review period. The extracorporeal membrane oxygenation machine market growth is mainly attributed to the large presence of key players, a growing number of product launches, high purchasing power parity, surging government support for quality healthcare, and increasing prevalence of chronic obstructive pulmonary disease, augmenting the regional market growth during the forecast timeline.

Asia Pacific is expected to grow at a healthy CAGR during the review period due to a surge in healthcare expenditure by the government as well as private agencies to improve healthcare facilities. Increasing government initiatives related to the development of healthcare infrastructure & reimbursement policies further bolsters the regional market growth.

Want to know which region offers the best growth opportunities? Register Here.

Key Players

The following are the key players in the extracorporeal membrane oxygenation machine market (arranged alphabetically).

• EUROSETS (Italy)
• Getinge (Sweden)
• Hemovent (Germany)
• LivaNova (UK)
• Medtronic (Ireland)
• MicroPort (China)
• Nipro (Japan)
• OriGen (US)
• Terumo (Japan)
• XENIOS (Germany)

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Research Methodology

This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s extracorporeal membrane oxygenation machine market realities and future market possibilities for the forecast period. The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for the market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate the growth strategies to expedite their growth process.

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Customization Option

Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players).
• SWOT analysis of key players (up to three players).

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.